Search
 
 
NEWS
 
Functional precision oncology leader Kiyatec announces Series C round with US$18 million closing to accelerate adoption of transformational cancer platform - Business Wire
Delegate Ronnie Campbell, R-Rockbridge, dies of cancer - Richmond Times-Dispatch
An Overview of Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer (RAI-R-DTC) - Targeted Oncology
Jemperli (dostarlimab) RUBY phase III trial met its primary endpoint in a planned interim analysis in patients with primary advanced or recurrent endometrial cancer - GSK
Dostarlimab Combination Shows Improved Endometrial Cancer Patient Survival at Trial Interim Analysis - Pharmacy Times